Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.23 USD | -6.26% | +9.35% | +11.63% |
Jun. 06 | Morgan Stanley Adjusts Price Target on Vir Biotechnology to $15 From $12, Maintains Equal-Weight Rating | MT |
Jun. 05 | Sector Update: Health Care Stocks Steady Premarket Wednesday | MT |
Financials (USD)
Sales 2024 * | 80.45M | Sales 2025 * | 38.54M | Capitalization | 1.53B |
---|---|---|---|---|---|
Net income 2024 * | -485M | Net income 2025 * | -579M | EV / Sales 2024 * | 9.92 x |
Net cash position 2024 * | 730M | Net cash position 2025 * | 669M | EV / Sales 2025 * | 22.3 x |
P/E ratio 2024 * |
-3.15
x | P/E ratio 2025 * |
-2.85
x | Employees | 587 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.24% |
Latest transcript on Vir Biotechnology, Inc.
1 day | -6.26% | ||
1 week | +9.35% | ||
Current month | +9.35% | ||
1 month | +17.71% | ||
3 months | -1.14% | ||
6 months | +16.74% | ||
Current year | +11.63% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | - | |
Sung Lee
DFI | Director of Finance/CFO | 53 | 23-03-26 |
Jennifer Towne
CTO | Chief Tech/Sci/R&D Officer | - | Nov. 05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Sigal
BRD | Director/Board Member | 72 | 20-07-01 |
Robert Perez
BRD | Director/Board Member | 59 | 16-12-31 |
Robert More
BRD | Director/Board Member | 56 | 16-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
12.90% | 208 M€ | +13.89% | - | |
0.63% | 28 M€ | -3.53% | ||
0.58% | 26 M€ | -4.59% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 11.23 | -6.26% | 2,231,201 |
24-06-06 | 11.98 | -5.37% | 1,702,938 |
24-06-05 | 12.66 | +19.66% | 3,486,411 |
24-06-04 | 10.58 | -0.47% | 746,964 |
24-06-03 | 10.63 | +3.51% | 982,795 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.63% | 1.53B | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- VIR Stock